ORIN1001 in Patients with Advanced Solid Tumors and Relapsed Refractory Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mothaffar F Rimawi, MD
Baylor College of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- University of Arizona Cancer Center
Tucson, Arizona, United States
- Ucla Health Burbank Specialty Care
Burbank, California, United States
- Ucla Health Laguna Hills Cancer Care
Laguna Hills, California, United States
- University of California Irvine Medical Center (ucimc) - Chao Family Comprehensive Cancer Center
Orange, California, United States
- University of California Los Angeles (ucla) - Jonsson Comprehensive Cancer Center (jccc) - Oncology Center - Westwood
Westwood, Los Angeles, California, United States
- University of Colorado Anschutz Medical Campus
Denver, Colorado, United States
- Highlands Ranch Hospital
Highlands Ranch, Colorado, United States
- University of Colorado Lone Tree Medical Center
Lone Tree, Colorado, United States
- University of Miami Hospital and Clinics - Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- Cancer Center of Kansas
Wichita, Kansas, United States
- St Lukes Cancer Institute
Kansas City, Missouri, United States
- Roswell Park Comprehensive Cancer Center (rpccc) (roswell Park Cancer Institute (rpci))
Buffalo, New York, United States
- Northwell Health
New Hyde Park, New York, United States
- Northwell Heath Cancer Institute
New Hyde Park, New York, United States
- Nyu Langone Health
New York, New York, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Baylor College of Medicine Medical Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 May 2019
- Primary completion
- 30 Jan 2023
- Completion
- 30 Jan 2023
- Last update posted
- 31 Dec 2024
- Registered enrollment
- 58
- Registry id
- NCT03950570
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.